Afrezza
My Prescription
Payment
Select pharmacy
$485.66
Print or send this coupon to your phone
AlbertsonsPowered byAbout Afrezza
Drug Details
Afrezza is an ultra rapid-acting inhaled insulin designed to manage high blood sugar levels in individuals with type 1 and type 2 diabetes. It is used in conjunction with a proper diet and exercise regimen. By inhaling this medication through the mouth, usually before meals, it aids in preventing complications associated with high blood sugar, such as kidney damage, vision problems, nerve damage, and cardiovascular issues. This synthetic insulin mimics the natural hormone your body produces, facilitating the absorption and storage of glucose in cells for energy while preventing the liver from generating excess glucose. Afrezza is absorbed into the bloodstream via the lungs, acting faster and for a shorter duration than traditional injected insulins. It is often used alongside medium- or long-acting insulin products but can also be combined with oral diabetes medications like metformin or used independently. However, Afrezza is not suitable for everyone. Individuals who smoke or have respiratory conditions such as asthma or COPD should avoid it, as it may cause serious side effects like bronchospasm. Common side effects include low blood sugar (hypoglycemia), cough, and throat irritation. Always consult a healthcare professional before using this medication to ensure it is safe and effective for your specific health needs.
Price history for Afrezza
90 Powders, 4UNIT
Average retail price for Afrezza
Average SaveHealth price for Afrezza
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Afrezza dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 4UNIT | 90 Powders | $485.86 | $5.40 |
| 8UNIT | 90 Powders | $948.39 | $10.54 |
| 12UNIT | 90 Powders | $1,420.27 | $15.78 |
| 60x4 &60x8 &60x12 UNIT | 180 Powders | $1,875.19 | $10.42 |
| 90 x 4 UNIT &90x8 UNIT | 180 Powders | $1,420.52 | $7.89 |
| 90 x 8 UNIT &90x12 UNIT | 180 Powders | $2,363.78 | $13.13 |
Afrezza FAQs
Afrezza has not been discontinued. It is an inhalable insulin used for managing blood sugar levels in individuals with diabetes. While it faced some challenges in terms of market adoption and distribution, it remains available for use. If there are concerns about its availability, it is advisable to consult a healthcare provider or pharmacist for the most current information.
The cost of the Afrezza inhaler can vary depending on factors such as the pharmacy, location, insurance coverage, and dosage required. Without insurance, the price can range from approximately $300 to $400 for a one-month supply. It is advisable to check with local pharmacies or insurance providers for the most accurate and up-to-date pricing information.
Yes, Afrezza is available in the United States. It is an inhaled insulin used to manage blood sugar levels in adults with diabetes.
The cost of Afrezza can vary based on factors such as insurance coverage, pharmacy pricing, and dosage requirements. Without insurance, the price can range from several hundred to over a thousand dollars per month. It is advisable for individuals to check with their insurance provider and local pharmacies for specific pricing and potential savings programs.
Inhaled insulin is not as popular as traditional insulin delivery methods due to several factors. Firstly, there are concerns about the long-term effects on lung health, as the safety profile is not as well established as that of injectable insulin. Additionally, inhaled insulin may not be suitable for all patients, particularly those with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). Moreover, the dosing of inhaled insulin can be less precise compared to injections, which may affect blood glucose control. The cost of inhaled insulin can also be higher, and it requires the use of a specific inhaler device, which may not be convenient for all patients. These factors contribute to its limited popularity among both patients and healthcare providers.